
Multi-panel OCR reading, standard capture, 48/72/96h time-series readings and ICDRG-based AI trend analysis — under one AI-assisted dermatology intelligence roof.
Digital Patch Test Tracking Platform — PatchTrack is an AI-assisted digital platform for patch test (epicutaneous test) tracking. It offers panel registration, standard capture, time-series readings and trend analysis under one roof with a four-phase workflow.
The system runs on OCR allergen list reading from panel photos, standard-format back photo capture, ICDRG scoring at 48/72/96h readings and LLM-based clinical trend commentary. All results support clinical decisions; they do not replace a medical diagnosis.
The platform combines optical character recognition (OCR), computer vision and large language model (LLM) multimodal inference. Panel photos are read via OCR, chamber reactions are detected via computer vision, and each time point is placed in clinical context by the LLM.
PatchTrack divides patch test tracking into four phases. Correct execution of each phase ensures reliable time-series comparison.
For each chamber, ICDRG score (negative/doubtful/weak/strong/extreme), papule (0-3), vesicle (0-3) and reaction area (mm²) are measured. ICDRG scoring follows international standards (International Contact Dermatitis Research Group).
PrickScan detects the wheal-and-flare reaction in the photo after the skin prick test (SPT) using AI; measures the longest + orthogonal diameter and calculates the wheal area.
It is normalized with positive control (histamine) and negative control (saline). Normalized index = wheal area / histamine area. Wheal count, flare diameter and AI clinical commentary are provided.
The platform supports clinical workflows as a screening and decision-support tool. ICDRG scores, time-series comparison and trend analysis provide the physician with structured, reproducible and comparable data.
The software-centric architecture aligns with EU carbon-reduction and ESG goals. Hardware independence brings medical consumable use close to zero.
The following studies demonstrate the clinical validity of patch test ICDRG scoring, contact dermatitis and prick test assessment.